HIF1A and neoplasm: As in Figure 2C, LEM more effectively inhibited sh-Scr E0771 tumor growth in C57BL/6 (Figure 3C) compared with NSG (Figure 3D) recipients; in contrast, LEM did not inhibit sh-Hif1a E0771 tumor growth, regardless of the recipient strain (Figure 3, C and D).